Calvin+&+Ivan

Plan
====The United States federal government should increase congressional oversight including; a prohibition on the monitoring of communications with those legally covered by a protected disclosure; mandate a requirement that federal agency employees participate in the Office of Special Counsel Whistleblower Protection Act certification program; mandate a legal review and express authorization before any potentially protected communication that is collected is shared. ====

Observation One: The Status Quo –
====In 2011 the Obama Administration began the Insiders Threat Program to surveil federal employees and monitor their moves at work to prevent national security leaks – the program continues today despite it having ZERO effectiveness==== WASHINGTON — In an initiative aimed at rooting out future leakers and other security violators AND of the NRC committee that wrote the report, said in an interview.
 * Landay 13**
 * (Johnathon, "U.S. Plan To Predict Future Leakers Isn't Likely To Work, Experts Caution," pg proquest //um-ef)**

Advantage 1: Whistleblowing –
====The insider threat program will be abused by agencies and used to undercut and intimidate potential federal whistleblowers – the reach of the program affects all federal employees creating a chilling effect==== (Scott, Higham writerIntelligence security initiatives have chilling effect on federal whistleblowers, critics say, https://www.washingtonpost.com/world/national-security/intelligence-security-initiatives-have-chilling-effect-on-federal-whistleblowers-critics-say/2014/07/23/c9dfd794-0ea0-11e4-8341-b8072b1e7348_story.html) JB The Insider Threat Program and a continuous monitoring initiative under consideration in the intelligence community AND and whistleblower, called the Insider Threat Program a "dangerous" initiative.
 * Washington Post 14**

And, the effect spills-over to EVERY agency – its targeted surveillance at every potential whistleblower
Gap 12- whistleblower protection and advocacy organization (Government Accountability Project, FDA Surveillance of Whistleblowers 'Unacceptable', http://whistleblower.org/press/fda-surveillance-whistleblowers-%E2%80%98unacceptable%E2%80%99) JB 'Chilling Effect' Far-Reaching if Congress Fails to Act (Washington, D AND -scientists who attempted to safeguard the public. This surveillance is unacceptable."

And, Only strengthening whistleblowers' rights solves – whistleblowers are an essential check on government fraud and abuse – lack of protections ensures a chilling effect that kills effectiveness
Congress and the President must mandate a government-wide policy to prevent future surveillance AND the most appropriate investigative tools" with which to investigate a suspected leak.
 * Anderson and Kleinman 14**
 * (Christine Anderson, Public Policy Fellow, POGO, and Avery Kleinman was the Beth Daley Impact Fellow for the Project On Government Oversight, "FDA Surveillance Threatened Whistleblowers," pg online @ http://www.pogo.org/blog/2014/02/fda-surveillance-threatened-whistleblowers.html //um-ef)**

And, the risk of Environmental collapse is high and coming – whistleblower protections are necessary – failure means the collapse of the planet and humanity from environmental deterioration
The changing environment may be one of the most pressing threats in all of human AND widespread social unrest, economic instability and loss of human life could result64.
 * Warren 15**
 * (Christopher K. Warren, Senior Note Editor, Boston College Environmental Affairs Law Review, 2014-2015, Boston College Environmental Affairs Law Review, 40 B.C. Envtl. Aff. L. Rev. 195, "Blowing The Whistle On Environmental Law: How Congress Can Help The Epa Enlist Private Resources In The Fight To Save The Planet," pg lexis//um-ef)**

And, Whistleblo**wers are necessary to help enforce environmental laws – key to effective implementation and prevention of environmental collapse
CONCLUSION The threats posed by climate change and environmental degradation are real and can only AND system is working properly, and thus protecting human health and the environment.
 * Warren 15**
 * (Christopher K. Warren, Senior Note Editor, Boston College Environmental Affairs Law Review, 2014-2015, Boston College Environmental Affairs Law Review, 40 B.C. Envtl. Aff. L. Rev. 195, "Blowing The Whistle On Environmental Law: How Congress Can Help The Epa Enlist Private Resources In The Fight To Save The Planet," pg lexis//um-ef)**
 * (Christopher K. Warren, Senior Note Editor, Boston College Environmental Affairs Law Review, 2014-2015, Boston College Environmental Affairs Law Review, 40 B.C. Envtl. Aff. L. Rev. 195, "Blowing The Whistle On Environmental Law: How Congress Can Help The Epa Enlist Private Resources In The Fight To Save The Planet," pg lexis//um-ef)**

FDA's in cohoots with big pharma- Reform is key to revitalize the agency
Do you read the labels of food and drugs to know exactly what you're getting AND ever that a serious role exists for hemp within the US and beyond.
 * Mercola No Date**- world-renowned physician and multiple New York Times bestselling author (Mercola, Dr. Joseph; The FDA exposed; mercola.com; no date; 08/07/15; http://www.mercola.com/downloads/bonus/the-FDA-exposed/default.aspx) JG

FDA's political posturing with regards to Marijuana is putting lives at risk, and they know it.
Almost four months after the U.S. Food and Drug Administration and the AND marijuana, there is a potential to actually cure many cases of PTSD.
 * Rucke 14**- a MintPress staff writer and investigative report specializing in the war on drugs, criminal justice, marijuana legislation, education and watchdog investigations as well as whistle-blowers (Rucke, Katie; 02/27/14; Mint Press News; Feds Block FDA-Approved PTSD-Marijuana Research; 06/13/15; www.mintpressnews.com/feds-block-fda-approved-ptsd-marijuana-research/180621/) JG

FDA's deliberately turning a blind eye- we need whistleblowers to come forward to expose this injustice.
Turning a blind-eye to marijuana's healing power "In light of all AND would put an end to the National Institute on Drug Abuse's marijuana monopoly.
 * Rucke 14**- a MintPress staff writer and investigative report specializing in the war on drugs, criminal justice, marijuana legislation, education and watchdog investigations as well as whistle-blowers (Rucke, Katie; 02/27/14; Mint Press News; Feds Block FDA-Approved PTSD-Marijuana Research; 06/13/15; www.mintpressnews.com/feds-block-fda-approved-ptsd-marijuana-research/180621/) JG

The feds still stand in the way of medicinal research and development- plan key to solve

 * Briggs 14**- nbc reporter (Briggs, Bill; JUL 29 2014; NBC News; Pot Researcher Firing Unleashes Rising Veteran Backlash; Backlashwww.nbcnews.com/health/kids-health/mom-who-lost-kids-says-babys-medical-condition-mistaken-abuse-n390121B; 07/13/15) JG

====A physician with federal approval to test if pot can treat PTSD became a scientist without a lab Tuesday after the University of Arizona refused to reverse her firing, and her private funders vowed to move her study to another college. But the termination of Dr. Sue Sisley already was fueling a larger backlash. Some of Sisley's supporters argue her dismissal embodies barriers that have long blocked marijuana from the medical mainstream. Those obstacles include, her backers say, a federal "monopoly" that chooses which scientists can investigate cannabis — and controls the price for exam-grade pot. Sisley's loudest fans are veterans who see hope in her planned study. They include Ricardo Pereyda, an Arizona alumnus diagnosed with Post-traumatic Stress Disorder after serving in Iraq. His online petition, dubbing Sisley's firing "immoral and unpatriotic," has amassed nearly 100,000 signatures. Facebook Twitter Google PlusEmbed Researcher seeks 'honest' discussion of pot and PTSD 1:18 Sisley herself sees irony in her own tale. She asserts that conservative state lawmakers in Arizona pushed the state-funded university to dump her. Yet, Sisley is a Republican who has never tried weed, she said, and admits she's "not sold" on its efficacy. "I'm pretty right wing. But these guys (in Arizona politics) hate marijuana research and have systematically tried to impede this because they believe it's a strategy for promoting marijuana legalization," Sisley told NBC News. "People are painting me like I have an agenda. But I'm just persuaded the drug has enough merit to deserve to be studied in a rigorous, controlled environment. I only care about doing quality science," she said. At the University of Arizona, officials declined to discuss why Sisley's faculty position was not renewed, calling it a "personnel matter." They denied politics played a role. "We have invested a lot of time and staff hours (in the Sisley study). We'd like to see the research continue here," said Chris Sigurdson, a university spokesman. "This is the kind of research we do to expand knowledge and look for innovative research and cures." But Sisley's private funders, a Santa Cruz, California, nonprofit — the Multidisciplinary Association for Psychedelic Studies (MAPS) — confirmed Tuesday it will hunt for a new home for the study, adding: "Were it not for Dr. Sisley's efforts, this research would not exist." Sisley's scientific plan was approved in March by the U.S. Department of Health and Human services. MAPS will buy research-grade cannabis for Sisley from the lone federal agency allowed to disperse it — the National Institute on Drug Abuse (NIDA). Sisley, thus, becomes the first U.S. researcher "with a goal of developing the marijuana plant in smoked form into an FDA-approved prescription medicine," said Rick Doblin, executive director of MAPS. But her termination, Doblin added, also reveals the barriers that keep Sisley's study the "only medical marijuana drug-development research currently being attempted in the U.S. ... despite there being a potential megabillion-dollar medical market." Those barriers, Doblin contends, include the "NIDA monopoly." That agency, part of National Institutes of Health, is authorized to grow research-grade marijuana at a University of Mississippi farm, then ship cannabis to federally approved scientists. But NIDA sets pot prices for private researchers, Doblin said. When he last asked that price "several years ago," NIDA quoted him $7 per gram. (By comparison, one Israeli research-pot producer offers marijuana to scientists at $1 per gram.) Further, NIDA has a legal boundary that cements its "monopoly" status, Doblin asserts. "NIDA is not authorized to provide marijuana for sale as an FDA-approved prescription medicine," Doblin said. "No pharmaceutical company, profit or nonprofit, would conduct expensive, multimillion-dollar … studies with a drug, like marijuana, that cannot be sold as a prescription medicine. "The NIDA monopoly has to end," Doblin added. According to NIDA officials, however, the agency has accepted 16 of 18 applications received since 1999 from privately funded U.S. researchers seeking research-grade pot. Those 16 approvals — including Sisley — all had received HHS endorsements. Their work includes scrutinizing pot in people with HIV, diabetes and multiple sclerosis. "Because NIDA manages the University of Mississippi farm contract, many people assume that NIDA controls who gets marijuana for research. This is inaccurate," said Dr. Jack Stein, director of NIDA's Office of Science Policy and Communications. "There is a three-step process that involves several federal agencies (including the Drug Enforcement Administration). NIDA would not decline to provide marijuana for a study that has successfully completed these requirements." Sisley may have HHS approval but she calls federal restrictions the top "hurdle" to good science. She also admits feeling a sense of urgency — hundreds of veterans have told her that pot helps control their PTSD symptoms, including depression, she said. "It's so sad that it requires political courage to do an FDA randomized control trial," Sisley said. "This isn't like some stoner saying, 'I want to do research.' This involves blinded, independent investigators just trying to collect objective data." Further, she knows from her conversations with ex-troops, PTSD contributes to an ongoing veteran suicide crisis. "The firing of Dr. Sue Sisley by the University of Arizona is an absolute abomination," said retired Marine and Iraq veteran Sean Azzariti, 32, who lives near Denver. He was diagnosed with PTSD and signed the online petition. "It's a disgusting, last-ditch effort by cannabis opponents to stall much-needed research." The research "should be fast-tracked, not bogged down by politics and bigotry. Let the science speak for itself," said Pereyda, the veteran behind the online protest. "Twenty-two veterans commit suicide every day — unfortunately many more will die before the research is====

FDA's complicity with big pharma has already lead to thousands of deaths
As long as dangerous drugs continue to rake in billions of dollars, the FDA AND the FDA. Click HERE to sign a petition and voice your outrage.
 * INH 13 **(The Institute for Natural Healing- an independent research organization; April 17, 2013; FDA and Big Pharma—Partners in Crime; 08/07/15; http://www.institutefornaturalhealing.com/2013/04/fda-and-big-pharma-partners-in-crime/) JG

Solvency mechanism
Oversight Constraints on Insider Monitoring Mandate Require certification and accountable to the American people. I look forward to your questions.
 * Canterbury 14**
 * (Angela, Director of Public Policy**
 * AND**

And, the signal of the plan must be clear and consistent and sent by congress – oversight is critical to ensure protections are enforced
Value of Whistleblowers To return to the theme I started on, whistleblowers need protection AND sure that whistleblowers continue to receive the kind of protection they need and deserve
 * Grassley 14**
 * (Chuck, Senator, "Sen. Grassley Talks About Anniversary Of Whistleblower Protection Act." Indian eGov Newswire 11 Apr. 2014. Infotrac Newsstand. //um-ef**)

====And, there is zero risk of offense, the insider threat program is a total disaster – it overextends agencies and creates a volume of useless information that only PREVENTS good governance (can be cut if too long)==== The Obama administration is now on an Angletonian path, but on a meta scale AND will overwhelm counter-intelligence investigators, counsel strongly against this Angletonian initiative.
 * Rottman 13**
 * (Gabe, "Obama's Whistleblower Witchunt Won't Work at DOD," pg online @ http://www.defenseone.com/management/2013/07/obama-whistleblower-witchhunt-wont-work-DOD/67598/ //um-ef)**